Found 40 matching trials
Vacuum Assisted Closure for Cesarean Section PHASE1 To study if incisional vacuum-assisted closure can decrease the risk of inf...
Show More Location
Dartmouth-Hitchcock Medical Center
Learn More & Join Trial
Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma PHASE2 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Nottingham City Hospital
Learn More & Join Trial
Mannitol Use During Cadaveric Kidney Transplantation NA We propose a placebo controlled randomized study on the use of mannitol as ...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Trial of Decitabine in Relapsed or Refractory T-lymphoblastic Lymphoma PHASE4 To explore the safety, tolerability, and clinical effects of decitabine com...
Show More Location
Oncology Department of The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
RNA-Immunotherapy of IVAC_W_bre1_uID and IVAC_M_uID PHASE1 The Mutanome Engineered RNA Immuno-Therapy (MERIT) study introduced a novel...
Show More Location
Johannes Gutenberg University
Learn More & Join Trial
Incisional Negative Pressure Dressing on Clean Closed Groin Incisions NA Wound complications associated with surgical incisions range from minor to ...
Show More Location
University of Maryland Medical Center
Learn More & Join Trial
Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI NA Patients with coronary artery disease and undergoing high-risk percutaneous...
Show More Learn More & Join Trial
A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL PHASE2 A Phase II Study of CODOX-M/ IVAC in Relapsed/Refractory ALL...
Location
Asan Medical Center
Learn More & Join Trial
A Safety and Immunogenicity Study of IVACFLU-A/H5N1 PHASE2 The study hypothesis was that two 0.5 mL doses of whole virion monovalent A...
Show More Location
Phase 3: Hai Phong Provincial Preventive Medicine Center
Learn More & Join Trial
This Study Was Conducted to Evaluate the Safety and Immunogenicity of IVACFLU-S Produced in Children From 6 Months to Under 18 Years Old and the Elderly Over 60 Years Old in Vietnam PHASE3 This was an extensive, double-blind, randomized, placebo-controlled phase 3...
Show More Learn More & Join Trial